Experimental procedures and NMR spectra for 4a-o and 5a, b, g-m, o, 6a, n, 7, 8, 9, 10.
General
NMR spectra were recorded on a Varian Gemini 2000 spectrometer, operating at 300 MHz for 1 [2] . AgSbF 6 , AgBF 4 and AgOTf were purchased from Aldrich. Phosphine ligands, PPh 3 and P(OPh) 3 were commercially available. Gold complexes [AuCl(ligand)] were synthesized by the reported method.
1 MS4A was purchased from Junsei Chemical Co. Anhydrous solvents used in the synthesis of materials were purchased from Kanto Chemical Co. and used without further purification. Anhydrous CH 2 Cl 2 and DCE were purchased from Kanto Chemical Co. and Aldrich, respectively, and these were degassed and dried with MS4A before use. Gel permeation chromatography (GPC) was performed by LC-908 (Japan Analytical Industry Ltd., two in-line JAIGEL-2H, CHCl 3 , 3.5 mL/min, UV and RI detectors). TLC analyses were performed on commercial glass plates bearing 0.25-mm layer of Merck Silica gel 60F 254 . Silica gel (Kanto Chemical Co., Silica gel 60 N, spherical, neutral) was used for column chromatography. PTLC purification was performed on commercial glass plates bearing 1-mm layer of Merck Silica gel 60F 254 . All reactions were carried out under argon atmosphere unless otherwise noted. 
Time-Conversion Profiles for the Gold-Catalyzed Cyclization of 4a with L1, X-Phos and IPr Ligands

Ts
[Au(NTf 2 )(L1)] (2.6 mg, 1.0 mol, 0.5 mol %) was placed in a NMR tube equipped with a screw cap. Separately, the alkynyl sulfonamide 4a (55 mg, 0.20 mmol) was weighed into a micro tube. The tubes were placed in a glove box. The gold complex and 4a were dissolved in degassed dry CDCl 3 (0.25 mL), in their respective tubes. Then Cl 2 CHCHCl 2 as an internal standard was added to a solution of the gold complex. A solution of 4a was transferred to a solution of the catalyst with a syringe. The remaining solutions in the micro tube and the syringe were washed with CH 2 Cl 2 (2 0.25 mL) and added to the reaction mixture. The tube was sealed with a cap equipped with a Teflon-coated silicon rubber septum. The tube was taken from the glove box, and was shaken at room temperature. The results with the corresponding ligands are shown in Table S1 and Figure S1 . 
Preparation of Substrates
Alkynyl sulfonamides 4a, 4b and alkynyl amine 4f were prepared by the alkylation of TsNH 2 , NsNH 2 or PMBNH 2 (2.0 eq) with the 7-iodo-1-trimethylsilyl-1-heptyne (1.0 eq) in the presence of CsCO 3 (1.2 eq) in DMF at 80 ˚C to 120 ˚C, followed by the deprotection of TMS group by K 2 CO 3 (1.2 eq) in MeOH at rt.
Alkynyl carbamates 4c, 4d and 4e were prepared by the protection of 6-heptyn-1-yl amine hydrochloride (1.0 eq) with N,N-dimethylaminopyridine (0.10 eq), Et 3 N (3.0 eq) and CbzCl or Ac 2 O or (Boc) 2 O (2.0 eq) in CH 2 Cl 2 at rt.
-Substituted alkynyl sulfonamides 4g, 4h, 4i and 4o were synthesized by the aziridine opening reactions of the corresponding N-tosyl aziridines (1.0 eq) with alkyl cuprates (1.5 eq) prepared from t BuLi (6.0 eq), 5-iodo-1-trimethylsilyl-1-pentyne (3.0 eq) and CuCN (1.5 eq) in THF at -78 ˚C, followed by the deprotection of TMS group by K 2 CO 3 (1.2 eq) in MeOH at rt. -Disubstiuted alkynyl sulfonamides 4j, 4k, 4l and benzyl sulfonamide 4m were prepared by the reaction of the corresponding alkynyl amines (1.0 eq) with TsCl (1.5 eq), Et 3 N (2.0 eq) and Me 3 NHCl (0.1 eq) in CH 2 Cl 2 at 0 ˚C. These amines were synthesized by the reductions of corresponding nitriles (1.0 eq) with LiAlH 4 (2.0 eq) in Et 2 O at reflux. N-Tosylbenzamide 4n was prepared by the reaction of N-tosyl isocyanate (1.0 eq) and o-alkynyl benzoic acid (1.0 eq) in the presence of Et 3 N (1.0 eq) in THF at reflux. 6a was synthesized by the reaction of N-tosyl -caprolactam (1.0 eq) with Cp 2 TiMe 2 (5.0 eq) in toluene at 70 ˚C [3] . N-[{1-(4-Pentyn-1-yl)cyclohexyl}methyl]-4-toluenesulfonamide (4l R)-2-Isopropyl-7-methyl-1-tosyl-2,3,4,5-tetrahydro-1H-azepine (5h , 3H), 1.13-1.34 (m, 2H), 1.64-1.74 (m, 2H), 1.75-1.90 (m, 2H), 2.04 (s, 3H), 2.42 (s, 3H),  3.60-3.69 (m, 1H) 
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